The Associate Director, Clinical Imaging will own the strategy and execution of sophisticated early and late phase oncology imaging in clinical trials where imaging plays a meaningful role. Imaging includes all modalities with a special focus on CT and PET. In this role, we expect you to lead the development of imaging biomarkers, support the scientific imaging aspects and tumor response assessment of oncology clinical studies. We assume you will be a member of cross-functional program teams including Regeneron clinical and preclinical colleagues as well as external academic and industry partners. We believe this opportunity provide excellent opportunities to develop innovative imaging biomarkers in support of clinical development and to contribute to bringing more treatment options to patients.

A Typical Day May Include:

• Work closely with imaging, therapeutic area and development leads to formulate appropriate imaging biomarker strategies to advise and advance the Regeneron clinical pipeline.

• Lead, design and implement multi-modality imaging measures as endpoints for oncology therapeutic clinical studies.

• Collaborate closely with Regeneron clinical teams as imaging subject matter expert to ensure optimal design and execution of imaging strategy including development of protocols, imaging manuals, imaging charters and statistical analysis plan.

• Work closely with Clinical Imaging Operations and imaging CROs to ensure the flawless conduct and data integrity of study’s imaging components and endpoints.

• Serve as Study Director for clinical trials focused on qualification and utilization of novel imaging biomarkers.

• Lead the interaction with regulatory agencies and site ethic committees for approval of clinical imaging biomarker development studies.

This Role May Be For You:

• You used the application of PET imaging as a quantitative endpoint in clinical and preclinical studies within Oncology

• You implemented central efficacy assessment using tumor response criteria such as RECIST 1.1, PCWG3, Lugano and IMWG in oncology clinical trials.

• You can clearly and effectively communicate across different modalities and settings

To be considered for this opportunity, we are expecting the candidates to have a minimum of 5 years of oncology drug development experience with a focus on clinical PET tracer development within the life science industry. We also are looking for you to have successful engagements with regulatory professionals. Lastly, we expect you to possess doctorate degree and 7+ years of experience of clinical imaging experience.

Does this sound like you? Apply now to take your first steps toward living the Regeneron Way! We have an inclusive and diverse culture that provides comprehensive benefits including health and wellness programs, fitness centers and equity awards, annual bonuses, and paid time off for eligible employees at all levels!

Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. We will ensure that individuals with disabilities are provided reasonable accommodations to participate in the job application process. Please contact us to discuss any accommodations you think you may need.

The salary ranges provided are shown in accordance with U.S. law and apply to U.S. based positions, where the hired candidate will be located in the U.S. If you are outside the U.S, please speak with your recruiter about salaries and benefits in your location.

Salary Range (annually)

$170,100.00 - $277,500.00